Distinctive immunomodulating properties and interactivity with model membranes and cells of two homologous muramyl dipeptide derivatives differing by their lipophilicity

International Journal of Immunopharmacology

Volumn 18, Issue 11, 1996, Pages 651-659

  Kalyuzhln, Oleg V ^a   Zemlyakov, Alexander E ^a   Fuchs, Boris B ^a  

^a RESEARCH INSTITUTE OF HUMAN MORPHOLOGY   (Russian Federation)

Author keywords

Biomembranes; Immunomodulation; Lipophilicity; Muramyl dipeptide derivatives

Indexed keywords

INTERLEUKIN 1; MURAMYL DIPEPTIDE DERIVATIVE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; ARTIFICIAL MEMBRANE; CELL STRAIN K 562; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG UPTAKE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; LIPOPHILICITY; LYMPHOCYTE PROLIFERATION; MEMBRANE BINDING; MIXED LYMPHOCYTE CULTURE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELL DIVISION; CELLS, CULTURED; FEMALE; INTERLEUKIN-1; KILLER CELLS, NATURAL; LEUKEMIA, ERYTHROBLASTIC, ACUTE; LYMPHOCYTE CULTURE TEST, MIXED; MACROPHAGES, PERITONEAL; MALE; MEMBRANES, ARTIFICIAL; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030291914     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(96)00061-6     Document Type: Article

References (29)

1. Bahr, G. M. & Chedid, L. (1986) Immunological activities of muramyl peptides. Fed. Proc., 45, 2541-2544.
2. Barratt, G. M., Puisieux, F., Yu, W. -P., Foucher, C., Fessi, H. & Devissaguet, J. P. (1994) Anti-metastatic activity of MDP-L-alanyl-cholesterol incorporated into various types of nanocapsules. Int. J. Immunopharmacol., 16, 457-561.
3. Cerrotini, J. C., Engers, H. D., MacDonald, H. R. & Brunner, K. T. (1974) Generation of cytotoxic T lymphocytes in vitro. I. Response of normal and immune spleen cells in mixed leukocyte culture. J. Exp. Med., 140, 703-717.
4. Chapes, S. K. & Haskill, S. (1982) Role of Corynebacterium parvum in the activation of peritonel macrophages. 1. Association between intracellular C. parvum and cytotoxic macrophages. Cell. Immun., 70, 65-75.
5. Dozmorov, I. M., Bagaeva, L. V., Kuzin, I. I., Svirchevskaya, E. V. (1991) Target cells for immunomodulatory action of muramyl dipeptide. Biomed. Sci., 2, 193-197.
6. Fidler, I. J., Fogler, W. E., Brownbill, A. E. & Schumann, G. (1987) Systemic activation of tumoricidal properties in mouse macrophages and inhibition of melanoma metastasis by the oral administration of MTP-PE, a lipophilic muramyl dipeptide. J. Immun., 138, 4509-4514.
7. Fidler, I. J., Sone, S., Fogler, W. E., Smith, D., Braun, D. G., Tarcsay, L., Gisler, R. H. & Schroit, A. J. (1982) Efficacy of liposomes containing a lipophilic muramyl dipeptide derivative for activating the tumoricidal properties of alveolar macrophages in vivo. J. Biol. Response Mod., 1, 43-45.
8. Fish, H. & Gifford, G. E. (1983) In vitro production of rabbit macrophage tumor cell cytotoxin. Int. J. Cancer, 32, 105-112.
9. 3H-labelled) with human blood monocytes. Int. J. Immunopharmacol., 9, 141-150.
10. Fogler, W. E. & Fidler, I. J. (1986) The activation of tumoricidal properties in human blood monocytes by muramyl dipeptide requires specific intracellular interaction. J.Immun., 136, 2311-2317.
11. Fogler, W. E., Talmadge, J. & Fidler, I. J. (1983) The activation of tumorocidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators. J. Reticuloendothel. Soc., 33, 165-174.
12. Karnovsky, M. L. (1986) Muramyl peptides in mammalian tissues and their effects at the cellular level. Fed. Proc., 45, 2556-2560.
13. Khachikyan, E. Y., Brondz, B. D., Drizlikh, G. I. & Egorova, S. G. (1978) Correlation between the cytotoxic T lymphocytes and suppressors blocking the DNA synthesis activation in mixed lymphocyte cultures. Bull. Exp. Biol. Med., 85. 189-192.
14. Kotani, S., Tsujimoto, M., Koga, T., Nagao, S., Tanaka, A. & Kawata, S. (1986) Chemical structure and biological activity relationship of bacterial cell walls and muramyl peptides. Fed. Proc., 45, 2534-2540.
15. Leclerc, C., Bourgeois, E. & Chedid, E. (1982) Demonstration of muramyl dipeptide (MDP)-induced T-suppressor cells responsible for MDP immunosuppressive activity. Eur. J. Immun., 12, 249-252.
16. Leclerc, C. & Chedid, L. (1983) Suppression of IL-2 production by muramyl dipeptide and derivatives. In Interleukins, limphokines and cytokines (ed. Oppenheim, J. J.), pp. 699-705. Academic Press, New York.
17. Lovett, D., Kozan, B., Hadam, M., Resch, K. & Gemsa, D. (1986) Macrophage cytotoxicity: interleukin 1 as a mediator of tumor cytostasis. J. Immun., 136, 340-347.
18. Morin, C., Barratt, G., Fessi, H., Devissaguey, J. P. & Puisieux, F. (1994) Improved intracellular delivery of muramyl dipeptide analog by means of nanocapsules. Int. J. Immunopharmacol., 16, 451-456.
19. 14C-labeled) in the mouse. Int. J. Immunopharmacol., 1, 35-41.
20. Pressman, B. C. (1976) Biological applications of ionophores. Annu. Rev. Biochem., 45, 501-530.
21. Schleifer, K. N. & Kandler, O. (1972) Peptidoglycan types ofbacterial cell walls and their taxonomic implications. Bact. Rev., 36, 407-477.
22. Stromberg, P. C., McMurray, D. N. & Brown, C. A. (1988) Inhibition of in vitro mitogen-induced lymphoproliferative response by sera from F344 rats with large granular lymphocyte leukemia. J. Clin. Lab. Immun., 25, 89-95.
23. Sugimoto, M., Germain, R. N., Chedid, L. & Benacerraf, B. (1978) Enhancement of carrier-specific helper T-cell function by the synthetic adjuvant N-acetyl-L-alanyl-D-isoglutamine (MDP). J. Immun., 120, 980-982.
24. Takada, H. & Kotani, S. (1985) Immunopharmacological activities of synthetic muramyl-peptides. In Immunology of the Bacterial Cell Envelope (eds Stewart-Tuil, D. E. S. & Davies, M.), pp. 119-151. Wiley & Son, Sussex, U.K.
25. Tanaka, A., Saito, R., Sugiyama, K., Morisaki, I., Kotani, S., Kusumoto, S. & Shiba, T. (1977) Adjuvant activity of synthetic N-acetylmuramyl peptides in rats. Infect. Immun., 15, 332-334.
26. Tobias, J. M., Argin, D. P. & Pawlowski, R. (1962) Phospholipid-cholesterol membrane model: control of resistance by ions or current flow. J. Gen. Physiol., 45, 989-1001.
27. Tsujimoto, M., Kotani, S., Kinoshita, F., Kanoh, S., Shiba, T. & Kusumoto, S. (1986) Adjuvant activity of 6-O-acylmuramyldipeptides to enhance primary cellular and humoral immune responses in guinea pigs: adaptibility to various vehicles and pyrogenicity. Infect. Immun., 53, 511-516.
28. Uede, T., Kohda, Y., Ibayashi, Y., Osawa, H., Diamantstein, T. & Kikuchi, K. (1986) Functional analysis of mononuclear cells infiltrating into tumors. II. Differential ability of mononuclear cells obtained from various tissues to produce helper factors that are involved in the generation of cytotoxic cells. J. Immun., 135, 3243-3251.
29. Zemlyakov, A. E. & Chirva, V. Y. (1987) Synthesis of glycoside analogues of N-acetyl-muramyl-L-alanyl-D-isoglutamine. Chem. Nat. Comp., 5, 714-718.